Ischemic heart disease (IHD) remains the leading cause of mortality globally, despite advancements in pharmacotherapy and revascularization techniques that ...

In the late 1960s, researchers at the Weizmann Institute of Science, including Professors Michael Sela and Ruth Arnon and Dr.

trientine hydrochloride is under development for treatment of ischemic heart disease, chronic heart failure, myocardial infarction, left ventricular ejection fraction and amyloidosis. It is ...

Explore the amazing power of heart regeneration. Discover how new research is changing the way we understand the human ...

Heart failure and arrhythmias together pose a critical healthcare issue with high risks of morbidity and mortality globally. Emerging evidence underscores ...

Patients with anorexia nervosa had a nearly fourfold higher risk for major adverse cardiovascular events than those without ...

The ISCHEMIA Trial randomly assigned patients with ischemic heart disease to an invasive treatment strategy centered on revascularization with a control group assigned non-invasive medical therapy. As ...

Researchers at 37 sites in South Korea have found patients taking clopidogrel after percutaneous coronary intervention (PCI) ...

A medical device company developing technology to improve outcomes for stroke patients will begin enrollment for a new ...

How to Choose the Best Hair Loss Treatment for You Finding the right hair loss treatment depends on the type and severity of your hair loss. With so many options available, it’s important to ...

Researchers suggest an application to FDA may be made within the next 12 months, requesting approval to carry out a human clinical trial with the gene therapy.